BMY: Breakout of the long-term resistance level.An upward breakout of the long-term resistance level could lead to an increase in the area of 81. In the long-term, the growth could continue to the area of 93.
BMY
I AM BULLISH ON BMYrisk reward tool gives you idea about ENTRY ,STOP LOSS AND TARGET
yes its good time to invest
when I get the idea that this script is not bullish anymore I will let you know guy
BMY divergence RSI on key level Daily chartwww.tradingview.com
Amazing RSI divergence on daily chart on a support key level.
Waiting confirmation with volume or candelstick to setup the perfect entry time.
Fibo 0.5 or 0.618 to be use for the TP as target.
To keep on watchlist.
BMY oversold! Price target and stop lossBristol-Myers Squibb Company (BMY) oversold on the daily!
Based on support and resistance we have:
Price target: 67.50usd
Stop loss: 55.90usd
BMY Flirting With Historic TerritoryWhen I say "historic" for BMY I'm not talking ATH but the stock's encroaching on an area that has been tested 3 times being rejected each time. This is the 236 fib area using 2016's high as the top anchor. It's been 5 years since BMY traded well above this area. But with the way attention is being placed on immunotherapy stocks, it could be something to keep in mind for BMY longs.
" Both Bristol-Myers and Novartis recently gave updates on new FDA updates. Novartis’ NIS793 gained FDA Orphan Drug Designation, while Bristol-Myers’ recent earnings update revealed strong sales figures from its lead cancer drug, Opdivo...B7H3 protein is a checkpoint molecule, which has very recently become a target for cancer treatment. While things are still in the very early stages for B7 molecules, as a whole, early research is also finding new potential for targeted cancer treatments. For instance, Merck’s (NYSE: MRK ) blockbuster drug, Keytruda, and Bristol-Myers’ YERVOY treatments target the same checkpoint inhibitors that are part of the B7 family (PD-1/PD-L1 and CTLA-4/CD80). They’ve also both demonstrated a clear survival benefit when it comes to immune-oncology treatment ."
Quote Source & Read More: Hot Biotech Stocks To Watch After Sanofi’s Acquisition Of Translate Bio
OSUR - 3M CHART - FINALLY READY FOR 15-20 RANGE?OSUR has enough failed attempts on both resistances I think it may just crack again sending it up to 16-20 range. Maybe even more. Do your own DD but it is extremely clear its very hard to get candles above the dual green zone of resistance and keep them up there longer term. Let's see how this next week or two play out. Could be interesting.
ABCL - WW - SMALL OTM OPTIONSAll, ABCL in a pretty solid spot here imo. Definitely need conformation of bottom here, candle looks to be a reversal possibly. I would look at 17-20$ calls OTM longer term or leveraged stock position hold long with a very tight stop loss. Could drop one more level. Just watch, slap some alerts on it but ABCL definitely imo worth 20-22.
Rising Wedge on BMYI see a 5 wave count rising wedge pattern forming on the weekly chart. Short target is $56
BMY - SEE YOU GUYS ON THE MOON 3M CHART - 85-100+Since 1969 BMY has been around yes. The fact this is chartable is wild. I think we see 70+ in 2-3 weeks 80+ after that new all time highs. I already am accumulating 700+ OTM options.
How to Develop a Short Trade using Top-Down AnalysisGood morning traders!
Today we want to show you a practical case of how to apply multiple timeframes for the complete development of a trade. In this case it is BMY stock, and it is a trade that we ourselves will take if what we are expecting happens.
🔸What can we find in this chart?
- First, what we can see is that in the 4H timeframe, the price has been moving in a range of 15-20% since May.
- A few days ago, the price faced the resistance zone that is around $64-66. We consider it a resistance zone since every time the price reaches that level, it encounters a strong supply, which generates its subsequent downward movement.
- Based on this, we decided that once a clear rejection was given, we would look for an opportunity to take a short trade.
🔸Descending to the 15Min chart, we see that after the rejection in the Resistance zone, the price generates a breakout of the Ascending Trendline.
- Added to this behavior, the Support zone is penetrated strongly to the downside, and then the price consolidates forming a corrective structure in a pullback to the Resistance zone (previous support).
- This is our opportunity to look for a short trade.
- The corrective structure offers us a correct and safe R/R ratio.
- The point where we will look for the entry of the trade will be in the breakout of the local low, with a stop loss behind the structure and the resistance zone.
- And finally, the maximum target of the movement is the uptrend line.
BMY accumulate on weakness -$55 CallsBMY might be ready to snap as it oscillates into earnings. Going to buy into weakness with a code red below $55 (unless this is post election over reaction)
BMY BUY OR LONG , TARGET UP TO $77.78BMY pattern confirmation Symmetrical triangle , the price is above the MA50 and MA200 support averages of the daily frame.
BMY buy : $63.5 +- 0.5
BMY target : $77.78
Stop loss : $60 (5-6%)
Wish you a good deal!
BMY = Long Term Bullish Chart = Cup-N-Handle !!!!! 8/2/2020What up you crazy mother-flowers !!!!!!
Check out BMY on the freaking long term chart!!!
= Cup-N-Handle on the monthly chart and targets on the chart>
= Also the weekly chart you see a possible Rising 3 methods in the making above 20-moving-average but not confirmed yet>
= You will find Inverse head and shoulders on the Daily/Weekly chart witch is working on the move up from the right shoulder>
= I'm looking into a long term option trade on this one here>
Let me know what ya'll think....
#BMY - possible Cup and Handle - Edit Alert #BristolMyersWait - until - alert clock - ringringringring.
BMY | 25 RSI | Profit opportunity | Extremely Bullish The current price of this stock is $56.22; this level is a huge support level if you take a look back to 2014, 2017, 2019. The chances for a huge bounce are very likely.
I was looking at the daily chart it has reached oversold conditions of 25.49, with today closing showing a bullish pin bar. The price has dropped from $65 to $55 since the start of June.
The 200 EMA is at $58, which is very far from the current price. The fib retracement tells us that it has tested the 61.8% retracement at $53.50.
I don't know the long term pattern, but it has to test the 200 EMA before it could go lower. During OCT 2019, we had a gap, and it could be coming back right now to fill that gap.
Trade safe and do your own DD.
